Intel at $85 After Its Best Day Since 1987: Can the Terafab Hype Survive a 125x Earnings Multiple?

Shares shifted again Monday as Intel added another 3.2% in pre-market trading to $85.20, extending a rally that already delivered the chipmaker's biggest single-day gain since 1987. Citi upgraded Intel to Buy from Neutral with a $95 price target, up from $48 , citing improving CPU demand from agentic AI. The question now: whether a stock up 100% year-to-date can justify a valuation that still prices in a turnaround largely unproven in hard cash flow.

• A Blowout Quarter Gave Bulls the Proof They Needed. Non-GAAP earnings hit $0.29 per share versus a $0.01 consensus, while revenue reached $13.6 billion, roughly a 9% beat.

The Data Center and AI segment grew 22% year over year to $5.05 billion , and non-GAAP gross margin reached 41%, exceeding guidance by 650 basis points. That margin expansion — driven by higher server chip volumes and pricing power — is the single most important number for investors because it signals Intel can sell more at better prices, not just grow revenue by spending more.

• Terafab and Tesla Add Credibility, Not Revenue — Yet. Intel is joining Elon Musk's Terafab project, a $25 billion semiconductor joint venture between Tesla, SpaceX, and xAI targeting massive AI compute at a facility in Austin, Texas. But external foundry revenue was just $174 million this quarter, and Tesla's commitment is not expected to substantially contribute to revenue before late 2027. The deal validates Intel's manufacturing ambitions but puts real money years away.

• Wall Street Is Deeply Split on What Comes Next. Evercore ISI moved to Outperform with a $111 target, though JPMorgan and BofA remain skeptical, citing foundry losses, negative free cash flow of $3.87 billion, and a forward P/E of 125x.

The consensus target sits at just $55.33, with 9 Buy, 33 Hold, and 6 Sell ratings — meaning most analysts think the stock is already overvalued at current levels.

• The Cash Burn Problem Hasn't Gone Away. Intel still reported a GAAP net loss of $3.73 billion, weighed down by a $4.07 billion restructuring charge.

Capital spending remains heavy at $4.96 billion for the quarter, and free cash flow was deeply negative.

Q2 guidance calls for revenue of $13.8–$14.8 billion , suggesting momentum is real. But Intel is betting billions on factories whose biggest external customers haven't yet written large checks. Until foundry losses narrow and free cash flow turns positive, the stock is running on conviction, not proof.